Fig. 4. Network pharmacology and functional enrichment analysis of the E. elaterium extracts in prostatic cancer, cervical cancer and lung cancer. (A) Venn diagram shows 53 common targets of compounds from the E. elaterium extracts in lung adenocarcinoma, cervical cancer and colorectal cancer. (B) Component-disease-target network diagram. (C) PPI network of 53 co-targeted genes/proteins. (D) GO enrichment analysis results for the anti-cancer targets. (E) Top 10 KEGG pathways enriched.
